Automated Assessment of PVI Using a Novel EP Recording System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.
Also called NCT05043883
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 101 participants
- Sponsor
- CathVision ApS
- Registry
-
NCT05043883
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, France
- Registry status
- Completed
Technical summary
Registry record NCT05043883. Allocation not applicable; no masking; primary purpose treatment. Start 2021-09-15 (actual); primary completion 2022-06-22 (actual). Results posted on 2024-08-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Automated Assessment of PVI Using a Novel EP Recording System
- Acronym
- PVISION
- Condition
- Paroxysmal Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- CathVision Cube® system
- Lead sponsor
- CathVision ApS
- Collaborator
- AKRN Scientific Consulting, S.L.
Record details
- Record id
cardio:ct-nct05043883- Content hash
38fcda24ed6d5baa3d4124a41a8a28e1d15674ed6a353670c0d2c5f4a630b01e